These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 20856141

  • 1. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.
    Valluri S, Zito JM, Safer DJ, Zuckerman IH, Mullins CD, Korelitz JJ.
    Med Care; 2010 Nov; 48(11):947-54. PubMed ID: 20856141
    [Abstract] [Full Text] [Related]

  • 2. Persisting decline in depression treatment after FDA warnings.
    Libby AM, Orton HD, Valuck RJ.
    Arch Gen Psychiatry; 2009 Jun; 66(6):633-9. PubMed ID: 19487628
    [Abstract] [Full Text] [Related]

  • 3. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.
    Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ.
    Am J Psychiatry; 2007 Jun; 164(6):884-91. PubMed ID: 17541047
    [Abstract] [Full Text] [Related]

  • 4. Antidepressants use in pediatric populations.
    Gören JL.
    Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
    [Abstract] [Full Text] [Related]

  • 5. Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.
    Gupta S, Gersing KR, Erkanli A, Burt T.
    Psychiatr Q; 2016 Jun; 87(2):329-42. PubMed ID: 26303613
    [Abstract] [Full Text] [Related]

  • 6. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.
    Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR.
    CNS Drugs; 2004 Jun; 18(15):1119-32. PubMed ID: 15581382
    [Abstract] [Full Text] [Related]

  • 7. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
    Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ.
    Am J Psychiatry; 2007 Aug; 164(8):1198-205. PubMed ID: 17671282
    [Abstract] [Full Text] [Related]

  • 8. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
    Cheung A, Sacks D, Dewa CS, Pong J, Levitt A.
    J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
    [Abstract] [Full Text] [Related]

  • 9. National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning.
    Mittal M, Harrison DL, Miller MJ, Brahm NC.
    Res Social Adm Pharm; 2014 Jun; 10(5):781-90. PubMed ID: 24355381
    [Abstract] [Full Text] [Related]

  • 10. The FDA pediatric advisories and changes in diagnosis and treatment of pediatric depression.
    Pfeffer CR.
    Am J Psychiatry; 2007 Jun; 164(6):843-6. PubMed ID: 17541037
    [No Abstract] [Full Text] [Related]

  • 11. National trends in prescribing antidepressants before and after an FDA advisory on suicidality risk in youths.
    Chen SY, Toh S.
    Psychiatr Serv; 2011 Jul; 62(7):727-33. PubMed ID: 21724784
    [Abstract] [Full Text] [Related]

  • 12. Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.
    Bushnell GA, Stürmer T, Swanson SA, White A, Azrael D, Pate V, Miller M.
    Psychiatr Serv; 2016 Mar; 67(3):302-9. PubMed ID: 26567938
    [Abstract] [Full Text] [Related]

  • 13. Changes in antidepressant medications prescribing trends in children and adolescents in Hawai'i following the FDA black box warning.
    Hassanin H, Harbi A, Saif A, Davis J, Easa D, Harrigan R.
    Hawaii Med J; 2010 Jan; 69(1):17-9. PubMed ID: 20222492
    [Abstract] [Full Text] [Related]

  • 14. A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills.
    Carson NJ, Progovac AM, Wang Y, Cook BL.
    Depress Anxiety; 2017 Dec; 34(12):1147-1156. PubMed ID: 28962069
    [Abstract] [Full Text] [Related]

  • 15. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
    Olfson M, Marcus SC, Druss BG.
    Arch Gen Psychiatry; 2008 Jan; 65(1):94-101. PubMed ID: 18180433
    [Abstract] [Full Text] [Related]

  • 16. Selective serotonin reuptake inhibitors in children and adolescents with major depression.
    Scahill L.
    Braz J Psychiatry; 2005 Jun; 27(2):91-2. PubMed ID: 15962129
    [No Abstract] [Full Text] [Related]

  • 17. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs.
    Morrato EH, Libby AM, Orton HD, Degruy FV, Brent DA, Allen R, Valuck RJ.
    Am J Psychiatry; 2008 Jan; 165(1):42-50. PubMed ID: 17986680
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.